Literature Review & Environmental Scan: SGBA+ in Drug Development
Task
As a four-person policy team, build the literature review and environmental scan that would ground a month-long federal policy simulation: identifying why Sex- and Gender-Based Analysis Plus (SGBA+) still isn't fully integrated into Canadian drug development, and what's already been tried elsewhere.
My Actions
Individually wrote the paper's introduction and its section on underrepresentation of women in cardiovascular research, grounding the whole team's paper in the FDA's history of formally excluding women from early-phase trials from 1977 to 1993, and in concrete consequences like 8 of the 10 prescription drugs withdrawn from the U.S. market between 1997 and 2001 posing greater risk to women. Combined that with teammates' sections on biological sex mechanisms, clinical presentation differences, and intersectional gaps to produce the full team paper, then helped translate the findings into our "Overview of Challenges" presentation to open the policy simulation.
Results
A literature base solid enough to carry the rest of the month's work: establishing that the real problem wasn't just underrepresentation in trials, but that even the sex data that is collected often isn't properly analyzed.
Literature Review, scroll to read
